Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT05811169
Eligibility Criteria:
Inclusion Criteria:
* Written Informed consent
* Patients ≥18 years of age, with histologically confirmed non-squamous non-small cell lung cancer who plan to receive active anti-cancer treatment for their non-small cell lung cancer.
* Sufficient tissues with a minimum of two tumour or nodal regions are available for the study based on pre-operative imaging and post-operative pathological findings.
Exclusion Criteria:
* Any other\* malignancy diagnosed or relapsed at any time, which is currently being treated (including by hormonal therapy).
Any other\* current malignancy or malignancy diagnosed or relapsed within the past 3 years\*\*.
\*Exceptions are: non-melanomatous skin cancer, stage 0 melanoma in situ, and in situ cervical cancer
\*\*An exception will be made for malignancies diagnosed or relapsed more than 2, but less than 3, years ago only if a pre-operative biopsy of the lung lesion has confirmed a diagnosis of NSCLC.
* Psychological condition that would preclude informed consent
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05811169
Study Brief:
Protocol Section:
NCT05811169